Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension.
Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension.
复制标题
DOI:
10.1016/j.jacc.2021.01.014
复制
发表时间:
2021-03-16
影响因子:
24
通讯作者:
Buckley LF
中科院分区:
文献类型:
--
作者:
Fatani N;Dixon DL;Van Tassell BW;Fanikos J;Buckley LF
Standard blood pressure control metrics may not account for changes in blood pressure over time. This study sought to estimate the independent association between time in systolic blood pressure target range and major adverse cardiovascular events among adults with hypertension. This study was a post-hoc analysis of SPRINT, a randomized clinical trial that compared intensive (<120 mm Hg) and standard (<140 mm Hg) systolic blood pressure treatment interventions in adults with hypertension and high cardiovascular risk. Target range was defined as 110–130 mm Hg and 120–140 mm Hg for the intensive and standard arms, respectively. Time in target range was estimated over the first 3 months of follow-up using linear interpolation. The association between time in target range with major adverse cardiovascular events was estimated using adjusted Cox proportional hazards regression models. Participants with greater time in target range were younger, had lower 10-year cardiovascular risk and lower baseline systolic blood pressure and were more likely women and statin users. Each 1-standard deviation increase in time in target range associated significantly with a decreased risk of first major adverse cardiovascular event in fully adjusted models. Time in target range remained significantly associated with major adverse cardiovascular events despite adjustment for mean systolic blood pressure or systolic blood pressure variability. Among participants with mean systolic blood pressure at or below target, time in target range remained associated with major adverse cardiovascular events. Time in systolic blood pressure target range independently predicts major adverse cardiovascular event risk. Each 1-standard deviation increase in time in target range associated significantly with a decreased risk of first major adverse cardiovascular event in fully adjusted models, after further adjustment for mean systolic blood pressure and among participants with mean systolic blood pressure at or below target. Time in systolic blood pressure target range independently predicts major adverse cardiovascular event risk. Time in target range may be a useful metric of blood pressure control for population-based quality assessment and clinical trial interventions.
登录
查看更多内容
影响因子:
37.8
作者:
Soliman EZ;Ambrosius WT;Cushman WC;Zhang ZM;Bates JT;Neyra JA;Carson TY;Tamariz L;Ghazi L;Cho ME;Shapiro BP;He J;Fine LJ;Lewis CE;SPRINT Research Study Group
通讯作者:
SPRINT Research Study Group
DOI:
10.1038/s41581-019-0244-2
发表时间:
2020-04
期刊:
Nature reviews. Nephrology
影响因子:
--
作者:
Mills KT;Stefanescu A;He J
通讯作者:
He J
DOI:
10.1177/1740774514537404
发表时间:
2014-10
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
Ambrosius WT;Sink KM;Foy CG;Berlowitz DR;Cheung AK;Cushman WC;Fine LJ;Goff DC Jr;Johnson KC;Killeen AA;Lewis CE;Oparil S;Reboussin DM;Rocco MV;Snyder JK;Williamson JD;Wright JT Jr;Whelton PK;SPRINT Study Research Group
通讯作者:
SPRINT Study Research Group
DOI:
10.1056/nejmoa1511939
发表时间:
2015-11-26
期刊:
The New England journal of medicine
影响因子:
--
作者:
SPRINT Research Group;Wright JT Jr;Williamson JD;Whelton PK;Snyder JK;Sink KM;Rocco MV;Reboussin DM;Rahman M;Oparil S;Lewis CE;Kimmel PL;Johnson KC;Goff DC Jr;Fine LJ;Cutler JA;Cushman WC;Cheung AK;Ambrosius WT
通讯作者:
Ambrosius WT
影响因子:
4
作者:
Schmitt, L;Speckman, J;Ansell, J
通讯作者:
Ansell, J